DE602004012731D1 - Zubereitungen mit verzögerter freigabe enthaltend zink, und herstellung derselben - Google Patents

Zubereitungen mit verzögerter freigabe enthaltend zink, und herstellung derselben

Info

Publication number
DE602004012731D1
DE602004012731D1 DE602004012731T DE602004012731T DE602004012731D1 DE 602004012731 D1 DE602004012731 D1 DE 602004012731D1 DE 602004012731 T DE602004012731 T DE 602004012731T DE 602004012731 T DE602004012731 T DE 602004012731T DE 602004012731 D1 DE602004012731 D1 DE 602004012731D1
Authority
DE
Germany
Prior art keywords
zinc
release composition
containing sustained
water
sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004012731T
Other languages
English (en)
Other versions
DE602004012731T2 (de
Inventor
Michio Kimura
Tomoko Eto
Yutaka Mizushima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTT Bio Pharma Co Ltd
Original Assignee
LTT Bio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTT Bio Pharma Co Ltd filed Critical LTT Bio Pharma Co Ltd
Publication of DE602004012731D1 publication Critical patent/DE602004012731D1/de
Application granted granted Critical
Publication of DE602004012731T2 publication Critical patent/DE602004012731T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602004012731T 2003-05-01 2004-04-01 Zubereitungen mit verzögerter freigabe enthaltend zink, und herstellung derselben Expired - Lifetime DE602004012731T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003126503 2003-05-01
JP2003126503 2003-05-01
PCT/JP2004/004791 WO2004096179A1 (en) 2003-05-01 2004-04-01 Zinc-containing sustained-release composition, its preparation, and method for producing the same

Publications (2)

Publication Number Publication Date
DE602004012731D1 true DE602004012731D1 (de) 2008-05-08
DE602004012731T2 DE602004012731T2 (de) 2009-04-09

Family

ID=33410296

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004012731T Expired - Lifetime DE602004012731T2 (de) 2003-05-01 2004-04-01 Zubereitungen mit verzögerter freigabe enthaltend zink, und herstellung derselben

Country Status (9)

Country Link
US (1) US7642230B2 (de)
EP (1) EP1620072B1 (de)
JP (1) JP4567668B2 (de)
CN (1) CN100364499C (de)
AT (1) ATE390126T1 (de)
DE (1) DE602004012731T2 (de)
ES (1) ES2300758T3 (de)
PL (1) PL1620072T3 (de)
WO (1) WO2004096179A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7534763B2 (en) 2004-07-02 2009-05-19 Bristol-Myers Squibb Company Sustained release GLP-1 receptor modulators
EP2021014A1 (de) 2006-05-26 2009-02-11 Brystol-Myers Squibb Company Glp-1-rezeptor-modulatoren mit verzögerter freisetzung
JP2009256241A (ja) * 2008-04-16 2009-11-05 Galenisearch Laboratories Inc 生理活性蛋白質含有ナノ粒子組成物およびその製造方法
EP2471554A1 (de) 2010-12-28 2012-07-04 Hexal AG Pharmazeutische Formulierung mit biopharmazeutischem Arzneimittel
CN110742065B (zh) * 2019-10-25 2021-07-27 山东农业大学 一种纳米花负载农药制剂及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US15737A (en) * 1856-09-16 Mode of attaching- shafts to sleighs
CA2150803C (en) * 1992-12-02 2006-01-31 Henry Auer Controlled release growth hormone containing microspheres
EP1002529A1 (de) 1994-09-09 2000-05-24 Takeda Chemical Industries, Ltd. Zubereitung mit verzögerter Freigabe eines Metallsalz eines Peptids
AU710347B2 (en) * 1995-08-31 1999-09-16 Alkermes Controlled Therapeutics, Inc. Composition for sustained release of an agent
DE69737995T2 (de) * 1996-06-20 2008-04-24 Novo Nordisk A/S INSULINPREPARATION MIT MAnnitol
EP0946169B1 (de) * 1996-12-20 2003-02-26 Takeda Chemical Industries, Ltd. Verfahren zur herstellung einer zusammensetzung mit verzoegerter abgabe
US6663899B2 (en) * 1997-06-13 2003-12-16 Genentech, Inc. Controlled release microencapsulated NGF formulation
US6998137B2 (en) * 2000-04-07 2006-02-14 Macromed, Inc. Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
JP2002348234A (ja) 2001-05-28 2002-12-04 Purotekku:Kk 薬物封入無機物微粒子、その製造法及び薬物封入無機物微粒子製剤
WO2003000282A1 (en) 2001-06-21 2003-01-03 Genentech, Inc. Sustained release formulation
JP2003081865A (ja) 2001-09-12 2003-03-19 Ltt Institute Co Ltd 水不溶性徐放性組成物、その製剤及びその製造方法

Also Published As

Publication number Publication date
EP1620072A1 (de) 2006-02-01
PL1620072T3 (pl) 2008-10-31
ATE390126T1 (de) 2008-04-15
EP1620072B1 (de) 2008-03-26
JP4567668B2 (ja) 2010-10-20
WO2004096179A1 (en) 2004-11-11
US7642230B2 (en) 2010-01-05
JP2006525319A (ja) 2006-11-09
CN1780607A (zh) 2006-05-31
US20060210629A1 (en) 2006-09-21
ES2300758T3 (es) 2008-06-16
DE602004012731T2 (de) 2009-04-09
CN100364499C (zh) 2008-01-30

Similar Documents

Publication Publication Date Title
CR8473A (es) Composicion farmaceutica de vinflunina para administracion parenteral y proceso de preparacion de dicha composicion
EA200400777A1 (ru) Фармацевтические композиции соединения платины
WO2014186937A1 (zh) 贻贝粘蛋白凝胶的制备方法、贻贝粘蛋白凝胶及其应用
BRPI0619399B8 (pt) derivado de metastina ou um sal do mesmo, e, medicamento
AR038947A1 (es) Suspension oral de sabor agradable y metodo
TNSN07419A1 (en) Methods for treating drug resistant cancer
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
MXPA02011389A (es) Forma de administracion farmaceutica para peptidos, procedimiento para su preparacion y aplicacion.
CN104918630A (zh) 抗药性癌细胞的抑制
DE502004008819D1 (de) Medikament zur wachstumsinhibierung von tumoren
WO2001060412A3 (en) Modification of biopolymers for improved drug delivery
DE60213395D1 (de) Chitosan-komplex zur krebsbehandlung unter bildung von autoaggregaten und herstellungsverfahren dafür
DE602004012731D1 (de) Zubereitungen mit verzögerter freigabe enthaltend zink, und herstellung derselben
CA2388395A1 (en) Compound
WO2004112838A3 (en) Codrugs of diclofenac
WO2010071320A3 (ko) 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물
NZ572366A (en) THE USE OF NICOTINE, ANALOGUES THEREOF, PRECURSORS THEREOF OR DERIVATIVES THEREOF IN THE TREATMENT OF VARIOUS PATHOLOGICAL PROCESSES CAPABLE OF IMPROVEMENT WITH a-MSH ADMINISTERED IN PROPHYLACTIC OR THERAPEUTIC FORM
RU2011130508A (ru) Рецептура для перорального трансмукозального применения гиполипидемических лекарственных средств
EP1634585A4 (de) Arzneimittel enthaltendes mikroteilchen mit verzögerter freisetzung, verfahren zu seiner herstellung und das mikroteilchen enthaltende zubereitung
RU2006145311A (ru) Твердая фармацевтическая композиция
JP2003508424A (ja) 真菌成長培地を用いる真菌感染の治療
US7893212B2 (en) S-nitroso group-containing albumin, method for production, and anticancer agent
KR101153250B1 (ko) 글리시리진 고농도 제제
TW200626133A (en) Oral medication for twice-daily administration
RU2010136277A (ru) Галеновая форма для трансмукозально-буккального введения триптанов

Legal Events

Date Code Title Description
8364 No opposition during term of opposition